;

Search Results:

Showing of 50

CLINICAL TRIAL16028

Transdisciplinary Research in Colorectal Cancer: Insulin-Like Growth Factor Axis and Colorectal Cancer

Cancer Type: Gastrointestinal Tumor

View Trial Details

CLINICAL TRIAL18345

A Phase 1 Trial of MK-3475 Plus Ziv-Aflibercept in Patients with Advanced Solid Tumors

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18855

Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18495

Caregiver Relationship Quality and Communication in Advanced Cancer Care

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18837

An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18396

A Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver who have Failed First Line Chemotherapy

Cancer Type: Gastrointestinal Tumor

View Trial Details

CLINICAL TRIAL18825

A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1522 in Patients with Advanced Breast Cancer and Other Advanced Tumors Expressing HER2

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL19103

Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative

Cancer Type: Healthy Subjects

View Trial Details

CLINICAL TRIAL19103

Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative

Cancer Type: Healthy Subjects

View Trial Details

CLINICAL TRIAL18891

A Multinational Open-Label, Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Administrations of NKR-2 in Patients with Different Metastatic Tumor Types

Cancer Type: Malignant Hematology

View Trial Details

CLINICAL TRIAL18051

A Phase 1, First-in-Human, Open Label, Dose Escalation Study of MGD007, A Humanized gpA33 x CD3 Dual-Affinity Re-Targeting (DART) Protein in Patients with Relapsed/Refractory Metastatic Colorectal Carcinoma

Cancer Type: Gastrointestinal Tumor

View Trial Details

CLINICAL TRIAL19112

DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL19100

Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction

Cancer Type: Gastrointestinal Tumor

View Trial Details

CLINICAL TRIAL19207

Phase II Study of Pembrolizumab in Advanced Poorly-Differentiated and/or High-Grade Neuroendocrine Tumors/Carcinomas

Cancer Type: Gastrointestinal Tumor

View Trial Details